Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-03-13 @ 6:29 AM
Study NCT ID:
NCT02951702
Status:
COMPLETED
Last Update Posted:
2017-12-27
First Post:
2016-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
Sponsor:
St. Luke's Hospital, Chesterfield, Missouri
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
940920-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None